1. Academic Validation
  2. Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription

Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription

  • J Biol Chem. 2001 May 25;276(21):18243-8. doi: 10.1074/jbc.M010815200.
G M Leong 1 N Subramaniam J Figueroa J L Flanagan M J Hayman J A Eisman A P Kouzmenko
Affiliations

Affiliation

  • 1 Bone & Mineral Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia. g.leong@garvan.unsw.edu.au
Abstract

Transforming growth factor-beta (TGF-beta) signaling requires the action of Smad proteins in association with Other DNA-binding factors and coactivator and corepressor proteins to modulate target gene transcription. SMAD2 and SMAD3 both associate with the c-Ski and Sno oncoproteins to repress transcription of Smad target genes via recruitment of a nuclear corepressor complex. Ski-interacting protein (SKIP), a nuclear hormone receptor coactivator, was examined as a possible modulator of transcriptional regulation of the TGF-beta-responsive promoter from the plasminogen activator inhibitor gene-1. SKIP augmented TGF-beta-dependent transactivation in contrast to Ski/Sno-dependent repression of this reporter. SKIP interacted with SMAD2 and SMAD3 proteins in vivo in yeast and in mammalian cells through a region of SKIP between Amino acids 201-333. In vitro, deletion of the Mad homology domain 2 (MH2) domain of SMAD3 abrogated SKIP binding, like Ski/Sno, but the MH2 domain of SMAD3 alone was not sufficient for protein-protein interaction. Overexpression of SKIP partially overcame Ski/Sno-dependent repression, whereas Ski/Sno overexpression attenuated SKIP augmentation of TGF-beta-dependent transcription. Our results suggest a potential mechanism for transcriptional control of TGF-beta signaling that involves the opposing and competitive actions of SKIP and Smad MH2-interacting factors, such as Ski and/or Sno. Thus, SKIP appears to modulate both TGF-beta and nuclear hormone receptor signaling pathways.

Figures